Stockreport

Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF Using the 2 Stage Free Cash Flow to Equity, Monopar Therapeutics fair value estimate is US$168 [Read more]